4D Molecular Therapeutics Inc
(FDMT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 7,421 | 3,633 | 3,535 | 0 |
| Gross Profit | 7,421 | 3,633 | 3,535 | N/A |
| Operating Expenses | 15,237 | 18,782 | 16,812 | 0 |
| Operating Income | -7,816 | -15,149 | -13,277 | N/A |
| Other Income | -17 | -4 | 117 | 0 |
| Pre-tax Income | -7,833 | -15,153 | -13,160 | 0 |
| Net Income Continuous | -7,833 | -15,153 | -13,160 | N/A |
| Net Income | $-7,833 | $-15,153 | $-13,160 | $N/A |
| EPS Basic Total Ops | -1.51 | -2.92 | -2.54 | N/A |
| EPS Basic Continuous Ops | -1.51 | -2.92 | -2.54 | N/A |
| EPS Diluted Total Ops | -1.51 | -2.92 | -2.54 | N/A |
| EPS Diluted Continuous Ops | -1.51 | -2.92 | -2.54 | N/A |
| EBITDA(a) | $-7,447 | $-14,790 | $-12,933 | $N/A |